Literature DB >> 7587059

The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.

P J Hurlin1, D E Ayer, C Grandori, R N Eisenman.   

Abstract

The small bHLHZip protein, Max, was originally identified through its interaction with Myc family proteins and appears to be an obligate partner for Myc function. Max has now been found to interact with at least two other proteins, Mad and Mxi1. These also belong to the bHLHZip class but are otherwise unrelated to Myc. Mad has been shown to abrogate the positive transcriptional activity of Myc and to inhibit Myc in co-transformation assays. This suggests that Mad may antagonize Myc function. Mad is rapidly induced upon differentiation, a time when Myc is frequently down-regulated. We show here evidence for Mad expression upon differentiation of myeloblasts, monoblasts, and keratinocytes. Mad:Max complexes are detected during differentiation and appear to replace the Myc:Max complexes present in proliferating cell populations. Since these complexes appear to form even in the presence of Myc, there may exist mechanisms that act to inhibit Myc:Max, or to promote Mad:Max, complex formation. We speculate that Max complex switching causes a change in the transcriptional activity of groups of target genes. Mad is not induced in all differentiating cell types, suggesting that other, possibly tissue-restricted, proteins might act in similar switch mechanisms to effect changes in transcriptional programs. We have also developed an approach to identification of the gene targets for Myc:Max complexes. By employing an immunoisolation procedure, we have begun characterization of several clones whose expression levels correlate with those of c-myc. Further identification of Myc-regulated genes may allow us to determine the molecular mechanism by which Myc governs cell proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7587059     DOI: 10.1101/sqb.1994.059.01.014

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  18 in total

Review 1.  Helix-loop-helix proteins in mammary gland development and breast cancer.

Authors:  Pierre-Yves Desprez; Tomoki Sumida; Jean-Philippe Coppé
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

Review 2.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

Review 3.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

4.  Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis.

Authors:  C Quéva; G A McArthur; B M Iritani; R N Eisenman
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription.

Authors:  Y Zhang; C Jones
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.

Authors:  C Grandori; J Mac; F Siëbelt; D E Ayer; R N Eisenman
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

7.  Expression of novel "LOCGEF" isoforms of ARHGEF18 in eosinophils.

Authors:  Keren B Turton; Emily M Wilkerson; Alex S Hebert; Frances J Fogerty; Hazel M Schira; Fady E Botros; Joshua J Coon; Deane F Mosher
Journal:  J Leukoc Biol       Date:  2018-03-30       Impact factor: 4.962

8.  Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium.

Authors:  Pawadee Lohavanichbutr; Lori C Sakoda; Christopher I Amos; Susanne M Arnold; David C Christiani; Michael P A Davies; John K Field; Eric B Haura; Rayjean J Hung; Takashi Kohno; Maria Teresa Landi; Geoffrey Liu; Yi Liu; Michael W Marcus; Grainne M O'Kane; Matthew B Schabath; Kouya Shiraishi; Stacey A Slone; Adonina Tardón; Ping Yang; Kazushi Yoshida; Ruyang Zhang; Xuchen Zong; Gary E Goodman; Noel S Weiss; Chu Chen
Journal:  Clin Cancer Res       Date:  2017-10-03       Impact factor: 12.531

9.  Mxi1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas.

Authors:  Lars D Engstrom; Andrew S Youkilis; Judith L Gorelick; Datong Zheng; Valerie Ackley; Christy A Petroff; Linda Q Benson; Melissa R Coon; Xiaoxiang Zhu; Samir M Hanash; Daniel S Wechsler
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

10.  ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4.

Authors:  M Pieraccioli; S Nicolai; A Antonov; J Somers; M Malewicz; G Melino; G Raschellà
Journal:  Oncogene       Date:  2015-08-24       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.